FAP and neoplasm: While increasing the total tumor radiation dose through repeated dosing with [225Ac]Ac-FAPI-46 resulted in limited tumor growth retardation in tumors with low FAP expression (parental FSA tumors), we show that higher FAP expression (FSA-F) correlates with improved FAP-RLT efficacy in immunocompetent animals.